J. Sisson

发表

131‐I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma

E. Kazerooni, T. Giordano, J. Sisson, 1996, Cancer.

Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine?

E. Kazerooni, T. Giordano, J. Sisson, 1998, Thyroid : official journal of the American Thyroid Association.

Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I.

B. Shulkin, J. Sisson, Susan A. Lawson, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.

I. Francis, B. Shulkin, J. Sisson, 1999, Radiology.

Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors.

G. Yanik, J. Sisson, 2012, Seminars in nuclear medicine.

The location of middle mediastinal pheochromocytomas.

M. Orringer, G. Glazer, I. Francis, 1984, The Journal of thoracic and cardiovascular surgery.

Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.

K. Koral, K. Frey, K. Wong, 2010, AJR. American journal of roentgenology.

Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma.

G. Glazer, B. Gross, I. Francis, 1983, AJR. American journal of roentgenology.

Plasma catecholamines in pheochromocytoma: effect of urographic contrast media.

G. Glazer, J. Raisanen, J. Sisson, 1984, AJR. American journal of roentgenology.

Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

W. Beierwaltes, J. Sisson, B. Shapiro, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.

W. Beierwaltes, J. Sisson, B. Shapiro, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Patterns of prolactin secretion in the syndrome of general resistance to thyroid hormones.

J. Sisson, B. Shapiro, S. Sauder, 1984, The Journal of clinical endocrinology and metabolism.

Current Trends in Functional Imaging of Pheochromocytomas and Paragangliomas

I. Ilias, K. Pacak, B. Shulkin, 2006, Annals of the New York Academy of Sciences.

Thyroid carcinoma.

J. Olson, J. Shah, R. Kloos, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Prognostic Implications of the Tall Cell Variant of Papillary Thyroid Carcinoma

R. Lloyd, W. Beierwaltes, J. Sisson, 1988, The American journal of surgical pathology.

Iodine-125-MIBG Therapy for Neuroblastoma—Reply

R. Wahl, R. Hutchinson, J. Sisson, 1991 .

Principles of, and pitfalls in, thyroid function tests.

J. Sisson, 1965, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PET hydroxyephedrine imaging of neuroblastoma.

R. Hutchinson, B. Shulkin, J. Sisson, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.

D. Kuhl, M. Schwaiger, I. Francis, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Staging of Differentiated Thyroid Carcinoma Using Diagnostic

K. Koral, K. Frey, K. Wong, 2010 .

131‐I‐Metaiodobenzylguanidine Treatment in Patients with Refractory Advanced Neuroblastoma

I. Francis, K. Zasadny, R. Hutchinson, 1992, American journal of clinical oncology.

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.

K. Matthay, G. Yanik, R. Hutchinson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.

K. Zasadny, R. Hutchinson, J. Sisson, 1991, Journal of nuclear biology and medicine.

Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies.

J. Sisson, D. Wieland, 1986, American journal of physiologic imaging.

Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.

J. Sisson, D. Wieland, M. Tobes, 1984, Molecular pharmacology.

Nuclear medicine imaging of pheochromocytoma and neuroblastoma.

B. Shulkin, J. Sisson, 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Determination of iodine-131 diagnostic dose for imaging metastatic thyroid cancer.

J. Sisson, S. Spaulding, J. Carey, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiation-Induced Osteosarcoma and Papillary Carcinoma of the Thyroid

G. Yanik, R. Hutchinson, B. Shulkin, 2006, Clinical nuclear medicine.

Scintigraphic localization of pheochromocytoma.

W. Beierwaltes, D. Swanson, J. Sisson, 1981, The New England journal of medicine.

Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors.

W. Beierwaltes, A. McEwan, J. Sisson, 1985, Seminars in nuclear medicine.

Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine.

W. Beierwaltes, D. Swanson, J. Sisson, 1981, Annals of internal medicine.

MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION

R. Lloyd, W. Beierwaltes, J. Sisson, 1984, Clinical endocrinology.

Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation

S. Gruber, C. Bradford, M. Marvin, 2009, Head & neck.

Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.

R. Lloyd, J. Sisson, M. Blaivas, 1985, The American journal of pathology.

The so-called stunning of thyroid tissue.

G. Doherty, A. Avram, J. Sisson, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma.

D. Goldstein, G. Eisenhofer, J. Sisson, 1986, Annals of internal medicine.

Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.

W. Beierwaltes, J. Sisson, B. Shapiro, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Referral patterns for patients with high-risk thyroid cancer.

J. Griggs, M. Banerjee, A. Stewart, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Reply: Stunning Effect

J. Sisson, 2007 .

Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.

B. Shulkin, J. Sisson, B. Shapiro, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.

W. Beierwaltes, R. Hutchinson, J. Sisson, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiolabeled meta-iodobenzylguanidine and the adrenergic neurons of salivary glands.

S. Fisher, J. Sisson, P. Sherman, 1987, American journal of physiologic imaging.

Salivary gland accumulation of meta-[131I]iodobenzylguanidine.

W. Beierwaltes, D. Swanson, J. Sisson, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Thyroid carcinoma.

J. Olson, J. Shah, R. Kloos, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Unusual complications of antithyroid drug therapy: four case reports and review of literature.

L. Fig, W. Beierwaltes, J. Sisson, 1989, Thyroidology.

Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.

J. Sisson, D. Wieland, M. Tobes, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis.

R. Lloyd, W. Beierwaltes, J. Sisson, 1982, Archives of internal medicine.

Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one.

J. Sisson, M. Tobes, S. Jaques, 1987, Cancer research.

Tomographic thyroid scintigraphy: comparison with standard pinhole imaging: concise communication.

K. Koral, W. Rogers, T. Brady, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Surgical treatment of cardiac pheochromocytomas.

M. Orringer, G. Glazer, I. Francis, 1985, The Journal of thoracic and cardiovascular surgery.

Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine.

T. Giordano, A. Avram, J. Sisson, 2009, Thyroid : official journal of the American Thyroid Association.

WhatPromisethePreliminaryTestsof CoronaryArteryDisease?

J. Sisson, 2006 .

Connective tissue activation. XVIII. Stimulation of hyaluronic acid synthetase activity.

J. Sisson, C. Castor, J. A. Klavons, 1980, The Journal of laboratory and clinical medicine.

131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.

W. Beierwaltes, J. Sisson, B. Shapiro, 1985, Cardiology.

Radioiodine Therapy and Graves' Ophthalmopathy

M. Schipper, J. Sisson, J. Freitas, 2008, Journal of Nuclear Medicine.

Scintigraphic detection of regional disruption of adrenergic neurons in the heart.

B. Lucchesi, J. Sisson, J. Lynch, 1988, American heart journal.

Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature.

A. Avram, J. Sisson, A. K. Vine, 2004, Journal of Clinical Endocrinology and Metabolism.

Familial extra-adrenal pheochromocytoma. A new syndrome.

R. Lloyd, A. Coran, W. Beierwaltes, 1985, Archives of internal medicine.

Alterations of Iodine-13 1 MIBG Biodistribution in an Anephric Patient: Comparison to Normal and Impaired Renal Function

L. Fig, J. Sisson, J. Carey, 2006 .

THERAPEUTIC NUCLEAR MEDICINE Radiopharmaceutical Treatment of Malignant Pheochromocytoma

W. Beierwaltes, D. Swanson, J. Sisson, 2006 .

Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine

W. Beierwaltes, R. Hutchinson, J. Sisson, 1991, European Journal of Nuclear Medicine.

Spectrum of pheochromocytoma in the131I-MIBG era

J. Sisson, N. Thompson, P. Cheung, 1988, World Journal of Surgery.

Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function.

L. Fig, J. Sisson, B. Shapiro, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.

L. Fig, J. Sisson, B. Shapiro, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction

J. Sisson, B. Shapiro, M. Gross, 1987, Journal of endocrinological investigation.

Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.

R. Lloyd, W. Beierwaltes, A. McEwan, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Scintigraphic Imaging of Pheochromocytomas by Means of Metaiodobenzylguanidine (MIBG)

W. Beierwaltes, J. Sisson, B. Shapiro, 1986 .

Effect of phenoxybenzamine on cardiovascular and plasma catecholamine responses to clonidine

James Sisson, J. Sisson, M. Gross, 1983, Clinical pharmacology and therapeutics.

Courses of Malignant Pheochromocytoma

B. Shulkin, J. Sisson, N. Esfandiari, 2006, Annals of the New York Academy of Sciences.

Biochemical Diagnosis and Localization of Pheochromocytoma

R. Reznek, A. Grossman, A. Sawka, 2006, Annals of the New York Academy of Sciences.

Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors.

R. Lloyd, J. Sisson, B. Shapiro, 1986, The American journal of pathology.

Thyroid function following neck irradiation for malignant lymphoma.

J. Sisson, Y. Kim, J. Fayos, 1980, Radiology.

First Description of Parathyroid Disease in Multiple Endocrine Neoplasia 2A Syndrome

S. Gruber, T. Giordano, G. Doherty, 2008, Endocrine pathology.

Iodine-125-MIBG to treat neuroblastoma: preliminary report.

R. Wahl, K. Zasadny, D. Normolle, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Orbital radiation for the ocular changes of Gravess' disease.

J. Sisson, J. Ravin, W. T. Knapp, 1975, American journal of ophthalmology.

Radiopharmaceuticals for nuclear endocrinology at the University of Michigan.

J. Sisson, 2000, Cancer biotherapy & radiopharmaceuticals.

Locating pheochromocytomas by scinTIGraphy using 131i‐metaiodobenzylguanidine

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, CA: a cancer journal for clinicians.

The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.

W. Beierwaltes, J. Sisson, B. Shapiro, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?

R. Burney, G. Doherty, B. Shulkin, 2003, Surgery.

Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.

K. Zasadny, W. Beierwaltes, J. Sisson, 1991, Journal of nuclear biology and medicine.

Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine

R. Hutchinson, J. Sisson, B. Shapiro, 2004, European Journal of Nuclear Medicine.

Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.

N. Petry, W. Beierwaltes, B. Shulkin, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.

J. Sisson, B. Shapiro, T. Mangner, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication.

W. Beierwaltes, D. Swanson, J. Sisson, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Metabolism of I-131-meta-iodobenzylguanidine (MIBG) in humans

J. Sisson, D. Wieland, T. Mangner, 1984 .

The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.

B. Shulkin, J. Sisson, B. Shapiro, 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Primary Extra-Adrenal Pheochromocytoma Positive I-123 MIBG Imaging with Negative I-131 MIBG Imaging

I. Francis, B. Shulkin, J. Sisson, 1986, Clinical Nuclear Medicine.

Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy.

W. Beierwaltes, J. Sisson, B. Shapiro, 1985, Radiology.

Intralesional triamcinolone therapy for pretibial myxedema.

J. Sisson, P. Lynch, P. G. Lang, 1975, Archives of dermatology.

Differentiated Thyroid Carcinomas: Treatment of Distant Metastases

W. Beierwaltes, J. Sisson, N. Thompson, 1974 .

SEQUESTERED NODULAR GOITER.

W. Beierwaltes, J. Sisson, R. Schmidt, 1964, The New England journal of medicine.

The dilemma of the solitary thyroid nodule: resolution through decision analysis.

S P Bartold, J C Sisson, J. Sisson, 1978, Seminars in nuclear medicine.

Iodine-131: optimal therapy for hyperthyroidism in children and adolescents?

D. Swanson, J. Sisson, M. Gross, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Follicular carcinoma of the thyroid with massive angioinvasion: extension of tumor thrombus to the heart.

M. Orringer, J. Sisson, R. Nishiyama, 1978, Surgery.

Pulmonary function in thyroid carcinoma metastatic to the lung

J. Sisson, C. Grum, L. Aldrich, 1987, Journal of endocrinological investigation.

Ectopic thyroid tissue in the neck. Benign or malignant?

J. Sisson, R. Nishiyama, N. Thompson, 1976, Cancer.

Serum thyroglobulin levels after thyroxine withdrawal in patients with low risk papillary thyroid carcinoma.

T. Giordano, D. Normolle, J. Sisson, 2000, Thyroid : official journal of the American Thyroid Association.

Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.

Ernest Frimpong Asamoah, James R Hurley, L. Dauer, 2011, Thyroid : official journal of the American Thyroid Association.

Practical dosimetry of 131I in patients with thyroid carcinoma.

J. Sisson, 2002, Cancer biotherapy & radiopharmaceuticals.

Thyroid carcinoma with high levels of function: treatment with (131)I.

J. Sisson, J. Carey, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Salivary Gland Accumulation of Meta-[

D. Swanson, J. Sisson, B. Shapiro, 2006 .

Surgical treatment of thyrotoxicosis in children and adolescents.

A. Coran, J. Sisson, R. Nishiyama, 1977, Journal of pediatric surgery.

Postoperative Evaluation of Thyroid Cancer Patients for Adequacy of Surgery and for Need of 131I Therapy

J. Sisson, 1989 .

Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

D. Rubello, A. Avram, J. Sisson, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

A phase II study of imatinib in patients with advanced anaplastic thyroid cancer.

T. Giordano, F. Worden, J. Sisson, 2010, Thyroid : official journal of the American Thyroid Association.

Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis.

S. Gruber, J. Sisson, V. Raymond, 2009, Thyroid : official journal of the American Thyroid Association.

Serious reactions to penicillin.

J. Sisson, D. C. Nilsson, 1960, Postgraduate medical journal.

Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism.

R. Wahl, J. Sisson, N. Thompson, 1994, Radiology.

QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy.

A. Vinik, J. Kahn, J. Sisson, 1987, The Journal of clinical endocrinology and metabolism.

Small cell tumors of the thyroid A clinicopathologic study

E. Rayfield, J. Sisson, R. Nishiyama, 1971, Cancer.

Lymphocyte-retrobulbar fibroblast interaction: mechanisms by which stimulation occurs and inhibition of stimulation.

J. Sisson, J. Vanderburg, J. A. Vanderburg, 1972, Investigative ophthalmology.

Compressive optic neuropathy in Graves’ eye disease

J. Sisson, B. Frueh, J. Arendshorst, 1983 .

The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts.

J. Sisson, H. Kirchick, P. Kothary, 1973, The Journal of clinical endocrinology and metabolism.

Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.

B. Shulkin, J. Sisson, B. Shapiro, 1999, American journal of clinical oncology.

Simultaneous scintigraphic depiction of aldosteronoma and adrenal infarction.

R. Gianchandani, J. Sisson, B. Shapiro, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Extra-adrenal and metastatic pheochromocytoma: The role of131I meta-iodobenzylguanidine (131I MIBG) in localization and management

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, World Journal of Surgery.

Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type II.

J. Sisson, R. Nishiyama, N. Thompson, 1977, Surgery.

Adrenocortical SPECT using iodine-131 NP-59.

J. Sisson, B. Shapiro, I. Hwang, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiopharmaceutical treatment of malignant pheochromocytoma.

W. Beierwaltes, D. Swanson, J. Sisson, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Treatment of malignant pheochromocytoma with a new radiopharmaceutical.

W. Beierwaltes, D. Swanson, J. Sisson, 1983, Transactions of the Association of American Physicians.

Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.

R. Wahl, M. Meyer, J. Sisson, 1993, The Journal of clinical endocrinology and metabolism.

MEN type IIa syndrome: dilemmas in modern management.

J. Sisson, N. Thompson, J. Freitas, 1978, Seminars in nuclear medicine.

Bilateral pheochromocytomas

R. Lloyd, W. Beierwaltes, J. Sisson, 1984, Journal of endocrinological investigation.

Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.

T. Giordano, A. Avram, J. Sisson, 2011, Thyroid : official journal of the American Thyroid Association.

Radiopharmaceutical Treatment of Pheochromocytomas

J. Sisson, 2002, Annals of the New York Academy of Sciences.

Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.

J. Sisson, B. Shapiro, I. Gough, 1985, Surgery.

An immunohistochemical study of pheochromocytomas.

R. Lloyd, J. Sisson, B. Shapiro, 1984, Archives of pathology & laboratory medicine.

Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function.

J. Sisson, P. Sherman, D. Wieland, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

MR Imaging of the Thyroid: Comparison with Scintigraphy in the Normal and Diseased Gland

J. Mountz, G. Glazer, J. Sisson, 1987, Journal of computer assisted tomography.

99mTc-pyrophosphate scan and radiographic correlation in thyroid acropachy: case report.

J. Thrall, J. Sisson, R. Seigel, 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Scintigraphy with I-131 MIBG as an aid to the treatment of pheochromocytomas in patients with the multiple endocrine neoplasia type 2 syndromes.

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, Henry Ford Hospital medical journal.

Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.

B. Shulkin, J. Sisson, B. Shapiro, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

62 FAMILIAL PARTIAL PERIPHERAL AND PITUITARY RESISTANCE TO THYROID HORMONE - A FREQUENTLY MISSED DIAGNOSIS?

J. Sisson, B. Shapiro, S. Sauder, 1985, Pediatric Research.

Stimulation of glucose utilization and glycosaminoglycans production by fibroblasts derived from retrobulbar tissue.

J. Sisson, 1971, Experimental eye research.

Functional aspects of fibroblasts derived from the retrobulbar tissue of man.

J. Sisson, J. Vanderburg, B. I. Spaugh, 1970, Experimental eye research.

Locating neuroblastoma in the opsoclonus-myoclonus syndrome.

R. Hutchinson, B. Shulkin, J. Sisson, 1994, Journal of nuclear biology and medicine.

Calcitonin, carcinoembryonic antigen and neuron‐specific enolase in medullary thyroid carcinoma. An immunohistochemical study

R. Lloyd, J. Sisson, P. Marangos, 1983, Cancer.

Thyroid carcinoma: Clinical practice guidelines

J. Olson, J. Shah, R. Kloos, 2005 .

Thyrotoxicosis caused by thyroid cancer.

J. Sisson, S. Paul, 1990, Endocrinology and metabolism clinics of North America.

Selection of the optimal scanning agent for thyroid cancer.

J. Sisson, 1997, Thyroid : official journal of the American Thyroid Association.

Hyperthyroidism Associated With Pregnancy

J. Hamburger, J. Sisson, L. G. Goluboff, 1974, Obstetrics and gynecology.

TSH Binding Inhibition Assay: Prediction and Treatment of Neonatal Graves' Disease

T. Whiteside, P. Hale, J. Sisson, 1991 .

Early diagnosis and thyroidectomy in multiple endocrine neoplasia, type 2b.

B. Jones, J. Sisson, 1983, The Journal of pediatrics.

Pretibial myxedema and nonthyrotoxic thyroid disease.

J. Sisson, J. Maize, P. Lynch, 1973, Archives of dermatology.

Radioiodine Therapy of Graves’ Disease

J. Sisson, B. Shapiro, M. Gross, 2000 .

Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.

E. Kazerooni, N. Petry, A. Driedger, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Measuring acute changes in adrenergic nerve activity of the heart in the living animal.

J. Sisson, G. Bolgos, J. Johnson, 1991, American heart journal.

Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy.

K. Koral, G. Glazer, R. Adler, 1989, International Journal of Radiation Oncology, Biology, Physics.

Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.

R. Norum, H. Willard, B. Ponder, 1990, Genomics.

Prediction of sudden cardiac death in diabetic autonomic neuropathy.

A. Vinik, J. Kahn, J. Sisson, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pheochromocytoma, polycythemia, and venous thrombosis.

B. Shulkin, J. Sisson, B. Shapiro, 1987, The American journal of medicine.

Specificity of radioiodinated MIBG for neural crest tumors in childhood.

R. Kloos, J. Lumbroso, B. Shulkin, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

J C Sisson, B L Shulkin, G. Yanik, 1996, Radiology.

"Myotonia" of the orbicularis oculi with myxedema.

W. Beierwaltes, J. Sisson, K. R. Magee, 1962, Archives of internal medicine.

"Myotonia" of the

W. Beierwaltes, J. Sisson, K. R. Magee, 2017 .

Procedure guideline for parathyroid scintigraphy

M. Sandler, G. Dillehay, B. Greenspan, 1998 .

Procedure guideline for parathyroid scintigraphy. Society of Nuclear Medicine.

M. Brown, M. Sandler, G. Dillehay, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomy.

D. Axelrod, J. Sisson, P. Gauger, 2003, Archives of Surgery.

The Society of Nuclear Medicine Procedure Guideline For Parathyroid Scintigraphy

M. Sandler, G. Dillehay, J. Sisson, 2004 .

Society of Nuclear Medicine Procedure Guideline for Parathyroid Scintigraphy version 2 . 0 , approved February 7 , 1999

G. Dillehay, J. Sisson, J. Seabold, 2002 .

Conjugate view gamma camera method for estimating tumor uptake of iodine-131 metaiodobenzylguanidine.

K F Koral, J C Sisson, B L Shulkin, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cardiac paragangliomas: A clinicopathologic and immunohistochemical study of four cases

M. Orringer, R. Lloyd, W. Beierwaltes, 1985, The American journal of surgical pathology.

Variation in the management of thyroid cancer.

J. Griggs, M. Banerjee, A. Stewart, 2013, The Journal of clinical endocrinology and metabolism.

The increasing incidence of thyroid cancer in Saudi Arabia.

J. Sisson, James C. Sisson, 1995, Annals of Saudi medicine.

Response to Beasley CW, Moore WH, and Wagner LK

J. Sisson, 2011 .

Cryptococcal thyroiditis and hyperthyroidism.

C. Jaffe, A. Avram, J. Sisson, 2004, Thyroid : official journal of the American Thyroid Association.

Simplified radioimmunoassay for triiodothyronine: evaluation of a new commercial kit.

S. Balachandran, J. Sisson, S. R. Patel, 1976, Clinical chemistry.

Phase II trial evaluating imatinib (I) in patients (pts) with anaplastic thyroid carcinoma (ATC).

T. Giordano, F. Worden, J. Sisson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected.

J. Sisson, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

What causes uptake of technetium-99m methylene diphosphonate by tumors? A case where the tumor appeared to secrete a hypercalcemia-causing substance.

J. Sisson, C. Stone, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine

K. Zasadny, D. Normolle, R. Hutchinson, 2004, European Journal of Nuclear Medicine.

Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.

I. Francis, K. Zasadny, D. Normolle, 1991, Journal of nuclear biology and medicine.

The crystal ball in the laboratory.

J. Sisson, 1979, Archives of internal medicine.

Clinical decision analysis. The hazard of using additional data.

J C Sisson, E. Schoomaker, J. Sisson, 1976, JAMA.

Medical treatment of benign and malignant thyroid tumors.

J. Sisson, 1989, Endocrinology and metabolism clinics of North America.

Proceedings: Differentiated thyroid carcinomas. Treatment of distant metastases.

W. Beierwaltes, J. Sisson, N. Thompson, 1974, Archives of surgery.

Thyroid carcinoma.

J. Olson, R. Kloos, D. Byrd, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Autoradiography-based, three-dimensional calculation of dose rate for murine, human-tumor xenografts.

R L Wahl, K F Koral, J C Sisson, 1993, Nuclear medicine and biology.

Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid Carcinoma

I. Mcdougall, I. Hay, J. Sisson, 2008, Journal of Nuclear Medicine.

Complementary Roles of CT and 131 I-MIBG Scintigraphy in Diagnosing Pheochromocytoma

G. Glazer, B. Gross, J. Sisson, 1984 .

Thyroid carcinoma: Clinical practice guidelines

J. Olson, R. Kloos, D. Byrd, 2005 .

Survival of patients with neuroblastoma treated with 125-I MIBG.

R. Hutchinson, B. Shulkin, J. Sisson, 1996, American journal of clinical oncology.

Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy.

R. Lloyd, J. Juni, J. Sisson, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Factors that influence radioactive iodine use for thyroid cancer.

M. Banerjee, M. Haymart, J. Sisson, 2013, Thyroid : official journal of the American Thyroid Association.

The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.

Clinical decision analysis. The hazard of using additional data.

E. Schoomaker, J. Sisson, J. Ross, 1976, Journal of the American Medical Association (JAMA).

Diagnosis of adrenal tumors with radionuclide imaging.

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, Special topics in endocrinology and metabolism.

LABELED PLASMA LIPIDS AFTER INGESTION OF RADIOACTIVE FATS.

J. Sisson, 1965, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.